4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Emcure Pharmaceuticals Limited (EMCURE) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Pune, India with about 6,914 employees. Its market capitalization is roughly ₹380 billion. In the fiscal year ended 2026-03-31, EMCURE reported ₹91.2B in revenue and ₹9.2B in net income.
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue | ₹91.2B | ₹78.1B | ₹65.8B | ₹59.3B | — |
| Gross Profit | ₹52.2B | ₹44.9B | ₹39.7B | ₹35.2B | — |
| Operating Income (EBIT) | ₹13.7B | ₹10.8B | ₹9.2B | ₹9.4B | — |
| Net Income | ₹9.2B | ₹6.8B | ₹5.0B | ₹5.3B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Total Revenue | ₹25.8B | ₹24.7B | ₹23.6B | ₹22.7B | ₹21.0B | — | — |
| Gross Profit | ₹15.1B | ₹14.7B | ₹14.0B | ₹13.8B | ₹13.0B | — | — |
| Operating Income (EBIT) | ₹4.0B | ₹3.8B | ₹3.6B | ₹3.3B | ₹3.0B | — | — |
| Net Income | ₹2.9B | ₹2.4B | ₹2.3B | ₹2.4B | ₹2.1B | — | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | (₹568M) | — | (₹542M) | (₹362M) | (₹542M) |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | ₹96.1B | ₹82.3B | ₹78.1B | ₹66.7B | — |
| Total Liabilities | ₹46.4B | ₹35.9B | ₹46.8B | ₹40.2B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive EMCURE viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms